HLA-C and neoplasm: However, some tumor cells develop the ability to evade the control of the immune system through a number of mechanisms (eg, loss or downregulation of tumor antigens and MHC (major histocompatibility complex) molecules, expression of inhibiting proteins, metabolic inhibition).6 Cancer immunotherapy focuses on overcoming immunoresistance of tumor cells to promote cancer eradication.